Clinical Trials

Toxic hepatitis

Displaying 2 studies

  • Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium La Crosse, WI; Albert Lea, MN; Rochester, MN

    To conduct a prospective, multicenter, observational study of patients with well-characterized alcoholic hepatitis (AH) and frequency matched individuals (by age, gender, and race) with comparable history of alcohol consumption but no clinical evidence of liver disease (controls). At the end of the study, a robust clinical information, central bio-repository will be developed from both cases and controls.

  • Dissecting the Genetic Environment Contributions of Autoimmune Liver Disease Rochester, MN

    The overall objective of this proposal is to conduct a systematic approach to dissect both genetic underpinnings and non-genetic factors in the development of adult autoimmune liver diseases including autoimmune hepatitis (AIH), overlap AIH with Primary Biliary Cirrhosis (AIH-PBC), overlap AIH with Primary Sclerosing Cholangitis (AIH-PSC), and drug-induced autoimmune-like hepatitis (DIAIH).

.

Mayo Clinic Footer